Rafferty Asset Management, LLC Bio N Tech Se Transaction History

Rafferty Asset Management, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 13, 2023	BUY	$118.43 - $186.05 $55,898 - $87,815	472 Added 25.88%	2,296 $344,000
Q3 2022 Nov 14, 2022	SELL	$127.65 - $183.11 $30,380 - $43,580	-238 Reduced 11.54%	1,824 $246,000
Q2 2022 Aug 12, 2022	BUY	$123.25 - $186.24 $28,470 - $43,021	231 Added 12.62%	2,062 $307,000
Q1 2022 May 13, 2022	BUY	$126.25 - $231.85 $84,461 - $155,107	669 Added 57.57%	1,831 $312,000
Q4 2021 Feb 10, 2022	BUY	$216.64 - $362.52 $251,735 - $421,248	1,162 New	1,162 $300,000

363

38.3M

2.45M

2.29M

Ticker BNTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 242,684,992
Market Cap $28.5B
Description
BioNTech SE, a biotechnology company, develops and commercializes immunotherapies for cancer and other infectious diseases. The company is developing FixVac product candidates, including BNT111, which is in Phase II clinical trial for advance melanoma; BNT112 that is in Phase I/IIa clinical trial for prostate cancer; BNT113, which is in Phase II...

Get notified when there are updates to the investment portfolio of Rafferty Asset Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Rafferty Asset Management, LLC with notifications on news.